Summary
In a significant market movement during November 2025, Scripta Therapeutics was the subject of a vc funding. The transaction achieved a gross valuation of £9,083,570. Leading the round was Parkwalk Advisors, Oxford Science Enterprises (OSE), Apollo Health Ventures, Oxford University Innovation Fund, YZR Capital, AlbionVC.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Parkwalk Advisors
Lead Investor / Acquirer
Oxford Science Enterprises (OSE)
Lead Investor / Acquirer
Apollo Health Ventures
Lead Investor / Acquirer
Oxford University Innovation Fund
Lead Investor / Acquirer
YZR Capital
Lead Investor / Acquirer
AlbionVC
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in